Evaxion Biotech (EVAX) Tops Q2 EPS by 10c

Evaxion Biotech (NASDAQ: EVAX) reported Q2 EPS of ($0.20), $0.10 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• CVG to join Russell 2000 and Russell 3000 indexes June 26
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity